Baydemir Gözde, Bereli Nilay, Andaç Müge, Say Ridvan, Galaev Igor Yu, Denizli Adil
Department of Chemistry, Biochemistry Division, Hacettepe University, Ankara, Turkey.
Colloids Surf B Biointerfaces. 2009 Jan 1;68(1):33-8. doi: 10.1016/j.colsurfb.2008.09.008. Epub 2008 Sep 18.
Recent years molecular imprinting has received considerable attention as an excellent and simple approach to recognize small molecules and bioactive substances. The aim of this study is to prepare the bilirubin-imprinted supermacroporous cryogels which can be used for the adsorption of bilirubin from human plasma. N-methacryloyl-(L)-tyrosinemethylester (MAT) was chosen as the pre-organization monomer. In the first step, bilirubin was complexed with MAT and the bilirubin-imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-(L)-tyrosine methylester) [BR-MIP] cryogel was produced by free radical polymerization initiated by N,N,N',N'-tetramethylene diamine (TEMED) and ammonium persulfate (APS) pair in an ice bath. After that, the template molecules (i.e., bilirubin) were removed from the polymeric structure using sodium carbonate and sodium hydroxide. The maximum bilirubin adsorption amount was 3.6 mg/g polymer. The relative selectivity coefficients of the BR-MIP cryogel for bilirubin/cholesterol and bilirubin/testosterone mixtures were 7.3 and 3.2 times greater than non-imprinted poly(HEMA-MAT) [NIP] cryogel, respectively. The BR-MIP cryogel could be used many times without decreasing bilirubin adsorption amount significantly. Therefore, as a reusable carrier possessing high selectivity, BR-MIP cryogel has a potential candidate as a clinical hemoperfusion material.
近年来,分子印迹作为一种识别小分子和生物活性物质的优秀且简单的方法受到了广泛关注。本研究的目的是制备可用于从人血浆中吸附胆红素的胆红素印迹超大孔冷冻凝胶。选择N-甲基丙烯酰基-(L)-酪氨酸甲酯(MAT)作为预组织单体。第一步,胆红素与MAT络合,然后在冰浴中通过N,N,N',N'-四甲基二胺(TEMED)和过硫酸铵(APS)引发的自由基聚合制备胆红素印迹聚(甲基丙烯酸羟乙酯-N-甲基丙烯酰基-(L)-酪氨酸甲酯)[BR-MIP]冷冻凝胶。之后,使用碳酸钠和氢氧化钠从聚合物结构中去除模板分子(即胆红素)。最大胆红素吸附量为3.6 mg/g聚合物。BR-MIP冷冻凝胶对胆红素/胆固醇和胆红素/睾酮混合物的相对选择性系数分别比非印迹聚(HEMA-MAT)[NIP]冷冻凝胶高7.3倍和3.2倍。BR-MIP冷冻凝胶可以多次使用而不会显著降低胆红素吸附量。因此,作为一种具有高选择性的可重复使用载体,BR-MIP冷冻凝胶有潜力成为临床血液灌流材料的候选者。